Ahjay - in the absence of actual ‘new news’ in the form of hard data or emerging fresh partnerships, I can’t help thinking that most of the price move north lately might just be on the coat tails of the biotech industry generally, which has - I think to a large degree - been caught up in the Covid cure speculation that’s rife across the market. There doesn’t appear to be any end in sight to the Fed’s green printing press. I reckon a lot of that hot money has been - and will continue to be - poured into (among other things) spec on biotechs.
SP hikes might be wishful thinking around impending LAG525 results ...or excitement about the boost from 200 to 2000 litres of efti - or neither. Your thoughts?
Ann: Change in substantial holding, page-9
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
32.0¢ |
Change
-0.015(4.48%) |
Mkt cap ! $465.4M | |||
| Open | High | Low | Value | Volume |
| 32.0¢ | 32.8¢ | 31.5¢ | $1.587M | 4.950M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 35998 | 32.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 32.5¢ | 286931 | 7 |
View Market Depth
| Last trade - 16.10pm 02/10/2024 (20 minute delay) ? |
| IMM (ASX) Chart |